CD44 and neoplasm: In the present study, we showed that Hedgehog inhibitor increased the sensitivity for anti-cancer drugs (Figure 2) and decreased expression of CD44, c-Myc and Nanog likely through the inhibition of GLI-1 in tumor ALI organoids (Figure 3).